We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

175 hedge funds and large institutions have $613M invested in Avadel Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 60 increasing their positions, 45 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 26

33% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 45

10% more funds holding

Funds holding: 159 → 175 (+16)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

1.93% less ownership

Funds ownership: 82.51% → 80.58% (-1.9%)

27% less capital invested

Capital invested by funds: $836M → $613M (-$223M)

44% less call options, than puts

Call options by funds: $2.25M | Put options by funds: $3.99M

Holders
175
Holders Change
+16
Holders Change %
+10.06%
% of All Funds
2.34%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
43
Increased
60
Reduced
45
Closed
26
Calls
$2.25M
Puts
$3.99M
Net Calls
-$1.74M
Net Calls Change
-$15.2M

Top Buyers

Rank Fund Capital Flow
1
BIP
Brandes Investment Partners
California
+$29.3M
2
Bank of America
Bank of America
North Carolina
+$8.67M
3
KAM
Krensavage Asset Management
New York
+$7.96M
4
TSC
Two Seas Capital
New York
+$5.44M
5
TCM
Tang Capital Management
California
+$5.02M

Top Sellers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
-$43.2M
2
TLP
Tri Locum Partners
New York
-$20.4M
3
Goldman Sachs
Goldman Sachs
New York
-$11.9M
4
CC
Checkpoint Capital
California
-$10.6M
5
Millennium Management
Millennium Management
New York
-$9.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
IAMOG
51
Investors Asset Management of Georgia
Georgia
$1.1M +$165K +19,700 +16%
SC
52
Schulhoff & Co
Ohio
$1.08M +$4.19K +500 +0.4%
SAM
53
Silverback Asset Management
North Carolina
$1.02M – – –
TI
54
Trexquant Investment
Connecticut
$1.01M +$1.08M +129,179 New
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
$995K +$24.2K +2,890 +2%
JP Morgan Chase
56
JP Morgan Chase
New York
$908K +$39.9K +4,762 +4%
KAM
57
Kazazian Asset Management
Florida
$831K +$788K +94,120 +784%
Point72 Asset Management
58
Point72 Asset Management
Connecticut
$823K +$880K +105,085 New
Cetera Investment Advisers
59
Cetera Investment Advisers
Illinois
$819K +$106K +12,603 +14%
LPC
60
Lion Point Capital
New York
$773K +$291K +34,700 +54%
Millennium Management
61
Millennium Management
New York
$747K -$9.35M -1,116,626 -92%
WC
62
Wexford Capital
Florida
$723K +$773K +92,310 New
Legal & General Group
63
Legal & General Group
United Kingdom
$660K -$3.55K -424 -0.5%
Wells Fargo
64
Wells Fargo
California
$659K +$8.16K +974 +1%
AllianceBernstein
65
AllianceBernstein
Tennessee
$651K -$114K -13,575 -14%
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$638K – – –
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$625K -$29.7K -3,541 -4%
CC
68
Centiva Capital
New York
$613K +$656K +78,317 New
Citigroup
69
Citigroup
New York
$578K -$67.4K -8,044 -10%
Cambridge Investment Research Advisors
70
Cambridge Investment Research Advisors
Iowa
$565K -$29K -3,465 -5%
OC
71
Oppenheimer & Co
New York
$532K +$7.04K +841 +1%
IIM
72
INTECH Investment Management
Florida
$519K +$63.1K +7,532 +13%
CIBC Private Wealth Group
73
CIBC Private Wealth Group
Georgia
$516K – – –
UBS AM
74
UBS AM
Illinois
$515K +$241K +28,836 +78%
HF
75
HRT Financial
New York
$504K +$540K +64,454 New
1 2
3
4 5

AVDL Hedge Fund Activity: Q1 2025 in Review

175 of the 7,464 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2025, worth a combined $613M — down 27% from $836M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new AVDL positions and 26 closed out — a net gain of 17 holders — while 60 added to existing stakes and 45 trimmed.

The largest buyer was Brandes Investment Partners, adding an estimated $29.3M. The largest seller was Braidwell, exiting entirely with an estimated $43.2M sold.

  • 175 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2025, up from 159 in Q4 2024.
  • Funds reported $613M of Avadel Pharmaceuticals stock for Q1 2025, down 27% quarter-over-quarter.
  • 43 funds opened new Avadel Pharmaceuticals positions in Q1 2025 and 26 closed out, a net change of +17 holders.
  • The largest Avadel Pharmaceuticals buyer in Q1 2025 was Brandes Investment Partners, an estimated $29.3M added.
  • The largest Avadel Pharmaceuticals seller in Q1 2025 was Braidwell, an estimated $43.2M sold.

Based on aggregated 13F filings for Q1 2025.